Skip to content

Clinical trials

Pulmonary Disease, Chronic Obstructive trials in Turkey (Türkiye)

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Disease, Chronic Obstructive Country / region: Turkey (Türkiye) Clear all

245 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20031
20063
20076
20083
20097
20104
20116
20123
20132
20143
20154
20162
20178
201814
201916
20208
202115
202224
202331
202440
202527
202616

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed156
Recruiting32
Unknown status32
Not yet recruiting8
Active, not recruiting8
Enrolling by invitation5
Terminated4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hacettepe University18
AstraZeneca17
Boehringer Ingelheim11
Novartis Pharmaceuticals10
Saglik Bilimleri Universitesi8
Neutec Ar-Ge San ve Tic A.Ş7
Novartis7
Abant Izzet Baysal University5
Bezmialem Vakif University5
Izmir Dr Suat Seren Chest Diseases and Surgery Education and Research Hospital5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Disease, Chronic Obstructive245
Dyspnea31
Anxiety Disorders11
Fatigue9
Pain7
Sleep Initiation and Maintenance Disorders7
Asthma6
Lung Diseases5
Respiratory Aspiration5
Bronchitis, Chronic4

Trials

Showing 51 to 75 of 245. Each trial links to its page on Pharma Observatory.

145 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.